Infections after living-donor liver transplantation

Surgical Infections

Volumn 7, Issue SUPPL. 2, 2006, Pages

  Gridelli, Bruno ^a   Panarello, Giovanna ^a   Gruttadauria, Salvatore ^a   Marcos, Amadeo ^a,b   Grossi, Paolo ^a,c  

^a MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; LOW MOLECULAR WEIGHT HEPARIN; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL INFECTION; ARTICLE; BILE DUCT OBSTRUCTION; BLOOD VESSEL SHUNT; CADAVER DONOR; CHOLANGITIS; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; GRAFT OCCLUSION; GRAFT RECIPIENT; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; LIVER FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; LIVING DONOR; MORPHOLOGY; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RELATIVE; RETRANSPLANTATION; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; URINARY TRACT INFECTION;

EID: 33748071120     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2006.7.s2-105     Document Type: Article

References (14)

1. Surman OS. The ethics of partial liver donation. N Engl J Med 2002;346:1038-1042.
2. Akabayashi A, Slingsby BT, Fujita M. The first donor death after living-related liver transplantation in Japan. Transplantation 2004;77:634-637.
3. Dondero F, Taille C, Mal H, Sommacale D, et al. Respiratory complications: A major concern after right hepatectomy in living liver donors. Transplantation 2006;81:181-186.
4. Brown Jr RS, Russo MW, Lai M, et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003;348:818-825.
5. Renz JF, Roberts JP. Long term complications of living donor liver transplantation. Liver Transplant 2000;6(Suppl):73-76.
6. Broelsch CE, Malago M, Testa G, et al. Living donor liver transplantation in adult: Outcome in Europe. Liver Transplant 2000;6(Suppl):64-65.
7. Beavers KL, Sandler RS, Shrestha R. Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: A systematic review. Liver Transplant 2002;8:110-117.
8. Richards PJ, Williams AS, Goodfellow RM, Williams BD. Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis. Rheumatology 1999;38:818-825.
9. Jose MD, Ikezumi Y, van Rooijen N, Atkins RC, Chadban SJ. Macrophages act as effector of tissue damage in acute renal allograft rejection. Transplantation 2003;76:1015-1022.
10. Sun Z, Wada T, Maemura K, et al. 2003. Hepatic allograft derived Kupffer cells regulate T cell response in rats. Liver Transplant 2003;9:489-497.
11. Russo MW, Galanko J, Beavers K, et al. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transplant 2004;10:340-346.
12. Yang ZF, Ho DW, Lau CK, et al. Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages. Int Immunol 2005;17:1391-1397.
13. Vargas HE, Laskus T, Wang L, et al. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl. Surg 1998;4:22-27.
14. Ghobrial RM, Amersi F, Farmer DG, et al. Rapid and severe early HCV recurrence following adult living donor liver transplantation. Am J Transplant 2002;2(Suppl 3):163.